New Patients: Supply will last roughly 13-14 weeks.
Maintenance Dose Patients (patients at the max dose): Supply will last 4 weeks.
Semaglutide is the first once-weekly medication in its class that’s FDA-approved to help with chronic weight management when used in combination with diet and exercise.
The largest clinical trial showed that people using semaglutide lost an average of 14.9% of their initial body weight — 12.4% more than those who didn’t use the medication.
Semaglutide is an injectable glucagon-like peptide-1 (GLP-1) agonist that’s administered once weekly. It was originally approved in 2017 — at a much lower dose — to help control blood sugar in type 2 diabetes under the brand name Ozempic. People taking Ozempic to help control blood sugar also tend to lose weight as an additional benefit.
Semaglutide is typically injected just under the skin (subcutaneously) in your abdomen, upper arm, or thigh. Avoid injecting the medication into the same spot every time — change your injection site with each dose. But injecting in the same body area (e.g., thigh) is OK as long as you’re rotating sites within the area each time.
Since semaglutide slows down how quickly food leaves your stomach, you may experience side effects like nausea and vomiting. Once you get started on the medication, your provider will slowly raise your dosage every 4 weeks to help make these effects more manageable.